N-[[(5-methyl-3-phenylisoxazol-4-yl)phenyl] sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration

John J. Talley, Stephen R. Bertenshaw, David L. Brown, Jeffery S. Carter, Matthew J. Graneto, Michael S. Kellogg, Carol M. Koboldt, Jinhua Yuan, Yan Y. Zhang, Karen Seibert

Research output: Contribution to journalLetterpeer-review

242 Scopus citations
Original languageEnglish
Pages (from-to)1661-1663
Number of pages3
JournalJournal of Medicinal Chemistry
Issue number9
StatePublished - 2000

Cite this